Latest filing published 01 Sept 2023 for Catalyst Biosciences, INC..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Andrea Hunt: trading record in brief
This profile gathers the share dealings of Andrea Hunt in Gyre Therapeutics, Inc., where the filings describe the role as board member. Between 31 December 2018 and 31 August 2023, the trades on record add up to 14 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Most recently, on 1 September 2023, the filings show a transaction in Gyre Therapeutics, Inc. Typically, a trade is published a median of 1 day after it takes place. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Andrea Hunt
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 28.228 sharesSeries Y Preferred StockSEC:0001140361-23-042368:0
- 7,521 shares0Common StockSEC:0001209191-22-002482:0
- 1,824 shares0Common StockSEC:0001209191-21-059427:0
- 2,886 shares0Common StockSEC:0001209191-21-044689:0
4 of 4 declarations
